20th Clinical Trials Innovation Programme: October 26 – 27, 2022

Join World BI and Redenlab for the 20th Clinical Trials Innovation Programme, to learn from experts in the drug development industry.

Hear from CEO Dr Adam Vogel and other leading industry experts exploring the future of clinical trials, patient centricity, and drug development digitalisation post COVID. 26 – 27 October 2022, Boston.

To find out more and register, click here.

Related Post

Redenlab selected for world-first international collaboration investigating neurofilament light chain and voice for diagnosing Dementia

  • Posted on 30 March, 2023
    Redenlab are partnering with Monash university, University of Melbourne, Eastern Health, and Invicta to deliver this world-first collaboration investigating neurofilament...
    Read more

    Simons Searchlight: Researcher Profile: Angela Morgan, PhD

    • Posted on 30 March, 2023
      Angela Morgan, PhD, is a National Health and Medical Research Council Elizabeth Blackburn Fellow and leads the Speech and Language...
      Read more

      The L16HTHOUSE Study

      • Posted on 30 March, 2023
        L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays in children...
        Read more